What is HempStreet?
HempStreet operates as India's premier research-to-retail venture, specifically targeting the intersection of traditional ayurvedic medicine and modern cannabis science. The company distinguishes itself through a rigorous commitment to research and development, collaborating with leading scientists to validate the safety and efficacy of cannabis-based medications. Beyond its clinical focus, HempStreet maintains a robust supply chain strategy, actively engaging with small-scale farmers through licensed contract farming initiatives. This dual-pronged approach—combining scientific validation with ethical, localized sourcing—positions the company as a vertically integrated leader in a highly regulated and emerging industry. By bridging the gap between laboratory innovation and consumer accessibility, HempStreet is effectively standardizing the delivery of cannabis-based therapeutic solutions across the Indian market.
How much funding has HempStreet raised?
HempStreet has raised a total of $1M across 1 funding round:
Other Financing Round
$1M
Other Financing Round (2023): $1M, investors not publicly disclosed
Key Investors in HempStreet
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for HempStreet?
With this major enterprise-level funding, HempStreet is poised to scale its operational footprint significantly. The strategic roadmap likely involves expanding its retail distribution network to ensure broader access to its proprietary medication line while simultaneously deepening its R&D pipeline. As the regulatory environment for cannabis in India continues to evolve, the company's focus on compliance and scientific integrity will be critical for long-term sustainability. Future growth will likely center on optimizing its contract farming ecosystem to ensure consistent quality control and supply chain resilience. By maintaining its commitment to ethical sourcing and evidence-based medicine, HempStreet is set to define the standards for the domestic ayurvedic cannabis sector, potentially attracting further institutional interest as it matures into a dominant market force.
See full HempStreet company page
